 Karen Wilson
Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tobacco Smoke Pollution | 24 | 2021 | 231 | 9.430 |
Why?
| | Cotinine | 10 | 2021 | 75 | 3.530 |
Why?
| | Smoking Cessation | 10 | 2023 | 407 | 2.790 |
Why?
| | Hospitalization | 23 | 2024 | 2070 | 1.750 |
Why?
| | Environmental Exposure | 5 | 2020 | 462 | 1.600 |
Why?
| | Electronic Nicotine Delivery Systems | 8 | 2023 | 89 | 1.550 |
Why?
| | Bronchiolitis | 5 | 2020 | 90 | 1.440 |
Why?
| | Marijuana Smoking | 3 | 2020 | 247 | 1.420 |
Why?
| | Housing | 4 | 2021 | 130 | 1.420 |
Why?
| | Hospitals, Pediatric | 16 | 2022 | 509 | 1.400 |
Why?
| | Smoke-Free Policy | 3 | 2021 | 13 | 1.390 |
Why?
| | Tobacco Products | 7 | 2024 | 110 | 1.370 |
Why?
| | Pediatrics | 8 | 2021 | 1052 | 1.370 |
Why?
| | Smoke | 4 | 2020 | 140 | 1.320 |
Why?
| | Parents | 9 | 2021 | 1309 | 1.290 |
Why?
| | Tobacco Smoking | 3 | 2021 | 25 | 1.190 |
Why?
| | Hospital Medicine | 4 | 2017 | 91 | 1.190 |
Why?
| | Child | 53 | 2024 | 20883 | 1.120 |
Why?
| | Vaping | 4 | 2023 | 54 | 1.100 |
Why?
| | Hospitalists | 5 | 2021 | 229 | 1.050 |
Why?
| | Child, Preschool | 36 | 2024 | 10517 | 0.970 |
Why?
| | Smoking | 11 | 2023 | 1501 | 0.950 |
Why?
| | Cannabis | 4 | 2021 | 465 | 0.950 |
Why?
| | Biomarkers | 5 | 2020 | 3973 | 0.930 |
Why?
| | Asthma | 9 | 2022 | 2230 | 0.910 |
Why?
| | Infant | 26 | 2024 | 9024 | 0.850 |
Why?
| | Adolescent | 45 | 2024 | 20393 | 0.820 |
Why?
| | Dronabinol | 3 | 2020 | 203 | 0.820 |
Why?
| | Child, Hospitalized | 3 | 2024 | 49 | 0.810 |
Why?
| | Rhabdomyolysis | 1 | 2022 | 22 | 0.790 |
Why?
| | Croup | 2 | 2022 | 26 | 0.780 |
Why?
| | Influenza, Human | 4 | 2017 | 601 | 0.770 |
Why?
| | Humans | 88 | 2024 | 129650 | 0.740 |
Why?
| | Length of Stay | 9 | 2022 | 1127 | 0.730 |
Why?
| | Seizures | 3 | 2018 | 402 | 0.680 |
Why?
| | Male | 58 | 2024 | 63681 | 0.670 |
Why?
| | Cesarean Section | 1 | 2020 | 182 | 0.620 |
Why?
| | Female | 58 | 2024 | 68776 | 0.610 |
Why?
| | Conversion Disorder | 1 | 2018 | 9 | 0.590 |
Why?
| | Patient Admission | 3 | 2018 | 182 | 0.580 |
Why?
| | Cytokines | 2 | 2018 | 2017 | 0.570 |
Why?
| | Air Pollution, Indoor | 1 | 2018 | 140 | 0.530 |
Why?
| | Medical Marijuana | 1 | 2018 | 111 | 0.530 |
Why?
| | Counseling | 4 | 2022 | 385 | 0.520 |
Why?
| | United States | 25 | 2024 | 13903 | 0.520 |
Why?
| | Medical Audit | 1 | 2016 | 77 | 0.510 |
Why?
| | Child Health | 1 | 2018 | 146 | 0.500 |
Why?
| | Retrospective Studies | 24 | 2022 | 14518 | 0.500 |
Why?
| | Systemic Inflammatory Response Syndrome | 3 | 2021 | 85 | 0.500 |
Why?
| | Personal Satisfaction | 1 | 2017 | 200 | 0.490 |
Why?
| | Dexamethasone | 5 | 2022 | 346 | 0.480 |
Why?
| | Encephalitis | 1 | 2017 | 133 | 0.480 |
Why?
| | Biomedical Research | 3 | 2017 | 638 | 0.470 |
Why?
| | Influenza Vaccines | 2 | 2017 | 532 | 0.470 |
Why?
| | Information Dissemination | 1 | 2017 | 206 | 0.460 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 790 | 0.460 |
Why?
| | Social Media | 1 | 2017 | 137 | 0.450 |
Why?
| | Smoking Prevention | 3 | 2021 | 163 | 0.440 |
Why?
| | Epilepsy | 1 | 2018 | 329 | 0.440 |
Why?
| | Colorado | 7 | 2020 | 4421 | 0.430 |
Why?
| | Health Policy | 1 | 2017 | 353 | 0.430 |
Why?
| | Pneumonia | 3 | 2019 | 616 | 0.420 |
Why?
| | Nonprescription Drugs | 3 | 2011 | 66 | 0.420 |
Why?
| | Leukocytosis | 1 | 2013 | 32 | 0.420 |
Why?
| | Inpatients | 5 | 2022 | 467 | 0.420 |
Why?
| | Complementary Therapies | 2 | 2006 | 87 | 0.420 |
Why?
| | Medication Errors | 2 | 2011 | 95 | 0.410 |
Why?
| | Adolescent Health Services | 3 | 2002 | 76 | 0.400 |
Why?
| | Internet | 1 | 2017 | 617 | 0.390 |
Why?
| | Tobacco Use | 2 | 2024 | 61 | 0.390 |
Why?
| | Abdominal Pain | 1 | 2013 | 144 | 0.380 |
Why?
| | Peer Review, Research | 1 | 2012 | 41 | 0.380 |
Why?
| | Patient Readmission | 6 | 2018 | 667 | 0.380 |
Why?
| | Infant, Newborn | 11 | 2021 | 5762 | 0.380 |
Why?
| | Vaccination | 2 | 2017 | 1348 | 0.370 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2011 | 90 | 0.360 |
Why?
| | Hypertension | 1 | 2020 | 1242 | 0.350 |
Why?
| | Health Services Research | 1 | 2013 | 391 | 0.350 |
Why?
| | New York City | 2 | 2021 | 81 | 0.350 |
Why?
| | Micronutrients | 1 | 2011 | 88 | 0.340 |
Why?
| | Carotid Arteries | 1 | 2011 | 196 | 0.340 |
Why?
| | Cohort Studies | 11 | 2023 | 5420 | 0.330 |
Why?
| | Child Welfare | 1 | 2011 | 211 | 0.330 |
Why?
| | Young Adult | 12 | 2024 | 12426 | 0.330 |
Why?
| | Inflammation Mediators | 1 | 2012 | 505 | 0.320 |
Why?
| | Tonsillectomy | 3 | 2015 | 82 | 0.310 |
Why?
| | Surveys and Questionnaires | 8 | 2023 | 5406 | 0.300 |
Why?
| | Cross-Sectional Studies | 9 | 2021 | 5066 | 0.300 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 253 | 0.280 |
Why?
| | Antioxidants | 1 | 2011 | 559 | 0.280 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2011 | 1279 | 0.270 |
Why?
| | Patient Discharge | 3 | 2018 | 857 | 0.270 |
Why?
| | Quality Improvement | 2 | 2022 | 1103 | 0.270 |
Why?
| | Sex Factors | 3 | 2020 | 1968 | 0.270 |
Why?
| | Adolescent Behavior | 3 | 2006 | 506 | 0.270 |
Why?
| | Adult | 16 | 2024 | 35576 | 0.260 |
Why?
| | Residence Characteristics | 2 | 2022 | 328 | 0.250 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2011 | 573 | 0.240 |
Why?
| | Electroencephalography | 2 | 2018 | 403 | 0.240 |
Why?
| | Dietary Supplements | 2 | 2006 | 534 | 0.230 |
Why?
| | Pandemics | 6 | 2023 | 1488 | 0.220 |
Why?
| | Universities | 3 | 2023 | 408 | 0.210 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2742 | 0.210 |
Why?
| | Socioeconomic Factors | 2 | 2018 | 1214 | 0.210 |
Why?
| | Perioperative Care | 2 | 2015 | 152 | 0.210 |
Why?
| | Delphi Technique | 1 | 2024 | 225 | 0.200 |
Why?
| | Marketing | 2 | 2019 | 28 | 0.200 |
Why?
| | Coitus | 1 | 2002 | 25 | 0.190 |
Why?
| | Risk Factors | 5 | 2020 | 9765 | 0.190 |
Why?
| | Diabetic Ketoacidosis | 2 | 2016 | 197 | 0.190 |
Why?
| | Tobacco Use Disorder | 1 | 2024 | 237 | 0.190 |
Why?
| | Public Housing | 1 | 2021 | 7 | 0.180 |
Why?
| | Consensus | 1 | 2024 | 616 | 0.180 |
Why?
| | Single-Blind Method | 1 | 2021 | 271 | 0.180 |
Why?
| | Caregivers | 2 | 2022 | 815 | 0.180 |
Why?
| | Guideline Adherence | 2 | 2015 | 526 | 0.170 |
Why?
| | Hospital Costs | 3 | 2016 | 114 | 0.170 |
Why?
| | Glucocorticoids | 2 | 2015 | 575 | 0.170 |
Why?
| | Contraception | 1 | 2002 | 153 | 0.170 |
Why?
| | Intensive Care Units | 2 | 2022 | 738 | 0.160 |
Why?
| | Health Care Costs | 1 | 2022 | 367 | 0.160 |
Why?
| | Prevalence | 2 | 2017 | 2564 | 0.160 |
Why?
| | Quality of Health Care | 2 | 2014 | 608 | 0.150 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 341 | 0.150 |
Why?
| | Coronavirus Infections | 2 | 2020 | 335 | 0.150 |
Why?
| | Attitude to Health | 2 | 2017 | 431 | 0.150 |
Why?
| | Nutrition Surveys | 1 | 2020 | 260 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1368 | 0.150 |
Why?
| | Behavior Control | 1 | 2018 | 15 | 0.150 |
Why?
| | Odds Ratio | 2 | 2018 | 1023 | 0.150 |
Why?
| | Nicotine | 2 | 2023 | 303 | 0.150 |
Why?
| | Weight Loss | 2 | 2018 | 734 | 0.140 |
Why?
| | Substance Abuse Detection | 1 | 2018 | 79 | 0.140 |
Why?
| | Respiratory Tract Diseases | 1 | 2019 | 148 | 0.140 |
Why?
| | Journal Impact Factor | 1 | 2017 | 29 | 0.140 |
Why?
| | Workload | 1 | 2019 | 153 | 0.140 |
Why?
| | Leadership | 1 | 2021 | 357 | 0.140 |
Why?
| | Limit of Detection | 1 | 2016 | 82 | 0.130 |
Why?
| | Tertiary Healthcare | 1 | 2016 | 29 | 0.130 |
Why?
| | Pregnancy | 3 | 2020 | 6402 | 0.130 |
Why?
| | Urinalysis | 1 | 2016 | 75 | 0.130 |
Why?
| | Infant, Low Birth Weight | 1 | 2017 | 135 | 0.130 |
Why?
| | Technology | 1 | 2017 | 86 | 0.130 |
Why?
| | Prospective Studies | 4 | 2022 | 7133 | 0.130 |
Why?
| | Health Behavior | 1 | 2002 | 741 | 0.130 |
Why?
| | Herbal Medicine | 2 | 2006 | 5 | 0.130 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 268 | 0.130 |
Why?
| | Video Recording | 1 | 2017 | 164 | 0.130 |
Why?
| | Oseltamivir | 1 | 2016 | 11 | 0.130 |
Why?
| | Publishing | 1 | 2017 | 140 | 0.120 |
Why?
| | Health Personnel | 2 | 2017 | 652 | 0.120 |
Why?
| | Migraine Disorders | 1 | 2017 | 101 | 0.120 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 857 | 0.120 |
Why?
| | Transcriptome | 1 | 2021 | 887 | 0.120 |
Why?
| | Subacute Care | 1 | 2016 | 77 | 0.120 |
Why?
| | Tobacco Industry | 1 | 2015 | 46 | 0.120 |
Why?
| | China | 1 | 2015 | 191 | 0.120 |
Why?
| | Immunization Schedule | 1 | 2016 | 197 | 0.120 |
Why?
| | Tobacco, Smokeless | 1 | 2014 | 10 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2002 | 894 | 0.120 |
Why?
| | Magnesium | 1 | 2015 | 153 | 0.120 |
Why?
| | Respiratory Tract Infections | 1 | 2019 | 376 | 0.120 |
Why?
| | Administration, Intravenous | 1 | 2015 | 141 | 0.110 |
Why?
| | Prednisone | 1 | 2015 | 233 | 0.110 |
Why?
| | Patient Handoff | 1 | 2014 | 31 | 0.110 |
Why?
| | Public Health | 1 | 2019 | 484 | 0.110 |
Why?
| | Steroids | 1 | 2015 | 158 | 0.110 |
Why?
| | Middle Aged | 6 | 2024 | 31154 | 0.110 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 146 | 0.110 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 125 | 0.110 |
Why?
| | Periodicals as Topic | 1 | 2017 | 204 | 0.110 |
Why?
| | Depressive Disorder | 1 | 2017 | 366 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1434 | 0.110 |
Why?
| | Role | 1 | 2013 | 32 | 0.110 |
Why?
| | Tachypnea | 1 | 2013 | 4 | 0.110 |
Why?
| | Research | 1 | 2017 | 416 | 0.110 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 275 | 0.110 |
Why?
| | Patient Care | 1 | 2014 | 109 | 0.110 |
Why?
| | Medical Errors | 1 | 2014 | 104 | 0.110 |
Why?
| | Hospitals, Community | 1 | 2013 | 48 | 0.110 |
Why?
| | Community-Acquired Infections | 1 | 2015 | 161 | 0.110 |
Why?
| | Wit and Humor as Topic | 1 | 2013 | 6 | 0.110 |
Why?
| | Cancer Survivors | 1 | 2018 | 263 | 0.100 |
Why?
| | Tachycardia | 1 | 2013 | 57 | 0.100 |
Why?
| | Postoperative Hemorrhage | 1 | 2014 | 87 | 0.100 |
Why?
| | Benchmarking | 1 | 2014 | 176 | 0.100 |
Why?
| | Wisconsin | 2 | 2023 | 99 | 0.100 |
Why?
| | Regression Analysis | 2 | 2016 | 993 | 0.100 |
Why?
| | Home Care Services | 1 | 2016 | 246 | 0.100 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1502 | 0.100 |
Why?
| | Probability | 1 | 2013 | 306 | 0.100 |
Why?
| | Survival Rate | 1 | 2017 | 1877 | 0.100 |
Why?
| | Health Resources | 1 | 2013 | 114 | 0.100 |
Why?
| | Interleukin-5 | 1 | 2012 | 45 | 0.100 |
Why?
| | Rural Population | 1 | 2016 | 518 | 0.100 |
Why?
| | Teaching Rounds | 1 | 2013 | 68 | 0.100 |
Why?
| | Efficiency | 1 | 2012 | 91 | 0.090 |
Why?
| | Interleukin-4 | 1 | 2012 | 212 | 0.090 |
Why?
| | beta Carotene | 1 | 2011 | 21 | 0.090 |
Why?
| | Patient Safety | 1 | 2014 | 287 | 0.090 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 516 | 0.090 |
Why?
| | Depression | 1 | 2020 | 1307 | 0.090 |
Why?
| | Comparative Effectiveness Research | 1 | 2012 | 149 | 0.090 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1501 | 0.090 |
Why?
| | Academic Medical Centers | 1 | 2013 | 481 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2019 | 10230 | 0.090 |
Why?
| | Comorbidity | 1 | 2015 | 1547 | 0.090 |
Why?
| | Critical Illness | 1 | 2016 | 758 | 0.090 |
Why?
| | Quality of Life | 2 | 2019 | 2704 | 0.080 |
Why?
| | Saliva | 1 | 2012 | 209 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2012 | 372 | 0.080 |
Why?
| | Antiviral Agents | 1 | 2016 | 712 | 0.080 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 90 | 0.080 |
Why?
| | Vitamins | 1 | 2011 | 174 | 0.080 |
Why?
| | Health Services Accessibility | 3 | 2021 | 902 | 0.080 |
Why?
| | Folic Acid | 1 | 2011 | 184 | 0.080 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2010 | 82 | 0.080 |
Why?
| | Health Surveys | 3 | 2006 | 494 | 0.080 |
Why?
| | Insulin Resistance | 1 | 2018 | 1165 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2736 | 0.080 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2011 | 119 | 0.080 |
Why?
| | Smokers | 2 | 2021 | 138 | 0.080 |
Why?
| | New York | 3 | 2006 | 128 | 0.080 |
Why?
| | Comprehension | 1 | 2011 | 165 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2012 | 273 | 0.080 |
Why?
| | Interferon-gamma | 1 | 2012 | 770 | 0.080 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2717 | 0.080 |
Why?
| | Health Literacy | 1 | 2011 | 161 | 0.080 |
Why?
| | Diabetes Mellitus | 1 | 2017 | 1001 | 0.080 |
Why?
| | Communication | 1 | 2014 | 846 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1838 | 0.080 |
Why?
| | Hospital Mortality | 2 | 2023 | 850 | 0.070 |
Why?
| | Health Care Surveys | 1 | 2010 | 559 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2470 | 0.070 |
Why?
| | Acetaminophen | 1 | 2011 | 246 | 0.070 |
Why?
| | Logistic Models | 1 | 2013 | 1988 | 0.070 |
Why?
| | Anti-Bacterial Agents | 2 | 2015 | 1717 | 0.070 |
Why?
| | Killer Cells, Natural | 2 | 2021 | 427 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 249 | 0.070 |
Why?
| | Anxiety | 1 | 2013 | 966 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2142 | 0.060 |
Why?
| | Preventive Medicine | 2 | 2005 | 41 | 0.060 |
Why?
| | Body Image | 1 | 2006 | 84 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3408 | 0.060 |
Why?
| | Internship and Residency | 1 | 2014 | 1053 | 0.060 |
Why?
| | Brain | 1 | 2017 | 2679 | 0.060 |
Why?
| | Medicare | 2 | 2022 | 720 | 0.060 |
Why?
| | Mass Screening | 1 | 2012 | 1149 | 0.060 |
Why?
| | Plant Extracts | 1 | 2006 | 199 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2535 | 0.050 |
Why?
| | Diet | 1 | 2011 | 1213 | 0.050 |
Why?
| | Pregnancy, Unwanted | 1 | 2002 | 14 | 0.050 |
Why?
| | CD57 Antigens | 1 | 2021 | 16 | 0.050 |
Why?
| | CD56 Antigen | 1 | 2021 | 36 | 0.050 |
Why?
| | Chemokine CCL3 | 1 | 2020 | 17 | 0.040 |
Why?
| | Homeless Youth | 1 | 2000 | 18 | 0.040 |
Why?
| | Intubation, Intratracheal | 1 | 2022 | 239 | 0.040 |
Why?
| | Qualitative Research | 2 | 2021 | 1235 | 0.040 |
Why?
| | Interleukin-17 | 1 | 2020 | 108 | 0.040 |
Why?
| | Causality | 1 | 2020 | 117 | 0.040 |
Why?
| | Immunity, Humoral | 1 | 2020 | 118 | 0.040 |
Why?
| | Intention | 1 | 2021 | 162 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2020 | 237 | 0.040 |
Why?
| | Down-Regulation | 1 | 2021 | 636 | 0.040 |
Why?
| | Canada | 1 | 2020 | 350 | 0.040 |
Why?
| | Age Factors | 1 | 2006 | 3144 | 0.040 |
Why?
| | Perception | 1 | 2021 | 340 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 637 | 0.040 |
Why?
| | Shock, Septic | 1 | 2020 | 209 | 0.040 |
Why?
| | Family | 1 | 2022 | 657 | 0.040 |
Why?
| | Suicidal Ideation | 1 | 2022 | 463 | 0.030 |
Why?
| | Peer Review | 1 | 2017 | 49 | 0.030 |
Why?
| | Substance-Related Disorders | 1 | 2006 | 1022 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1587 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2020 | 601 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2017 | 216 | 0.030 |
Why?
| | Medically Underserved Area | 1 | 2016 | 84 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1206 | 0.030 |
Why?
| | Drug Utilization | 1 | 2016 | 171 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2021 | 578 | 0.030 |
Why?
| | Organizational Case Studies | 1 | 2014 | 75 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1295 | 0.030 |
Why?
| | Propensity Score | 1 | 2015 | 265 | 0.030 |
Why?
| | Birth Weight | 1 | 2017 | 505 | 0.030 |
Why?
| | Antiemetics | 1 | 2014 | 41 | 0.030 |
Why?
| | Workflow | 1 | 2014 | 155 | 0.030 |
Why?
| | Social Facilitation | 1 | 2013 | 10 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2644 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2015 | 2483 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 541 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 759 | 0.030 |
Why?
| | Autoantibodies | 1 | 2020 | 1466 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1928 | 0.020 |
Why?
| | Medicaid | 1 | 2016 | 433 | 0.020 |
Why?
| | Rabbits | 1 | 2013 | 778 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1720 | 0.020 |
Why?
| | Drug Labeling | 1 | 2011 | 41 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1269 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4897 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 1902 | 0.020 |
Why?
| | Drug Therapy | 1 | 2005 | 80 | 0.010 |
Why?
| | Life Style | 1 | 2006 | 460 | 0.010 |
Why?
| | Aged | 1 | 2022 | 22103 | 0.010 |
Why?
| | Risk-Taking | 1 | 2006 | 347 | 0.010 |
Why?
| | Focus Groups | 1 | 2005 | 453 | 0.010 |
Why?
| | Age Distribution | 1 | 2000 | 372 | 0.010 |
Why?
| | Sex Distribution | 1 | 2000 | 359 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2000 | 522 | 0.010 |
Why?
| | Animals | 1 | 2013 | 35361 | 0.010 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|